We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Analysis of Genes That Predispose People to Develop High Blood Pressure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00522119
Recruitment Status : Completed
First Posted : August 29, 2007
Last Update Posted : March 31, 2017
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Maryland

Brief Summary:
High blood pressure affects nearly one third of all individuals in the United States. It is believed that genetic factors may predispose some people to develop this disease. This study will identify and characterize variations in three genes known to play a part in the development of high blood pressure.

Condition or disease

Detailed Description:
High blood pressure is one of the most common health problems in this country. It can be caused by many factors, including stress, diet, diabetes, kidney disease, or obesity. In many people, there is no identifiable cause for their high blood pressure. If high blood pressure goes untreated, it can lead to heart failure, kidney failure, or stroke. Previous studies have shown that variations in three genes in chromosome 1—ATP1B1, RGS5, and SELE—cause some people to be more susceptible to developing high blood pressure. All three of these genes are involved in the development of proteins that play a role in regulating blood pressure, but it is not known exactly how variations in these genes affect blood pressure levels. This study will examine previously collected genetic samples from participants in two clinical trials, the GenNet study and the Heredity and Phenotype Interaction (HAPI) Heart study. Study researchers will analyze the samples to identify and characterize variations in the ATP1B1, RGS5, and SELE genes. Results from this study may lead to more effective diagnostic and treatment options for people with high blood pressure.

Study Type : Observational
Time Perspective: Retrospective
Official Title: Genetic and Functional Analyses of Chromosome 1 Hypertension Susceptibility
Actual Study Start Date : August 2003
Primary Completion Date : July 2006
Study Completion Date : July 2011

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Participants in the GenNet and HAPI Heart studies (genetic samples will be examined)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00522119

Sponsors and Collaborators
University of Maryland
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Yen Pei C. Chang, PhD University of Maryland

Responsible Party: University of Maryland
ClinicalTrials.gov Identifier: NCT00522119     History of Changes
Other Study ID Numbers: 1403
R01HL088120 ( U.S. NIH Grant/Contract )
R01HL088120-01A1 ( U.S. NIH Grant/Contract )
First Posted: August 29, 2007    Key Record Dates
Last Update Posted: March 31, 2017
Last Verified: March 2017

Keywords provided by University of Maryland:
Essential Hypertension
High Blood Pressure

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases